Costs associated with multidrug-resistance in inpatient palliative care

Adelhardt T, Hessemer S, Heckel M, Herbst FA, Stiel S, Ostgathe C, Schöffski O (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Gesundheitsökonomie und Qualitätsmanagement Georg Thieme Verlag

Book Volume: 24

Pages Range: 185-190

Journal Issue: 4

DOI: 10.1055/a-0651-6448

Abstract

The study deals with the financial impact of the occurrence of multidrug-resistant pathogens on a palliative care unit of a German university hospital. Aims of the study are an analysis of the cost drivers as well as a cost comparison between MDRO-positive and -negative patients.

Authors with CRIS profile

Thomas Adelhardt Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement Stefanie Hessemer Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement Maria Heckel Department of Palliative Medicine Christoph Ostgathe Department of Palliative Medicine Oliver Schöffski Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement

Involved external institutions

Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE)

How to cite

APA:

Adelhardt, T., Hessemer, S., Heckel, M., Herbst, F.A., Stiel, S., Ostgathe, C., & Schöffski, O. (2019). Costs associated with multidrug-resistance in inpatient palliative care. Gesundheitsökonomie und Qualitätsmanagement, 24(4), 185-190. https://dx.doi.org/10.1055/a-0651-6448

MLA:

Adelhardt, Thomas, et al. "Costs associated with multidrug-resistance in inpatient palliative care." Gesundheitsökonomie und Qualitätsmanagement 24.4 (2019): 185-190.

BibTeX: Download